Biopharma Business

Tag "Humira"

EU review for Sandoz’ Humira, Remicade biosimilars

    EU review for Sandoz’ Humira, Remicade biosimilars

European regulators have accepted for review Sandoz’ marketing applications for biosimilars to AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab). The company is seeking approval for its biosimilars for use in

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements